Table 4.

No. and rate of patients with PsA who achieved PASDAS ≤ 1.9, PASDAS LDA, MDA 5/7, MDA 7/7, DAPSA ≤ 4, or DAPSA LDA with residual disease activity/functional impairment in the single domains. Values are n (%).

VariablesTJC > 1SJC > 1HAQ > 0.5PASI > 1LEI > 1
PASDAS ≤ 1.90003 (23)0
PASDAS LDA2 (5)1 (2.6)4 (10.5)8 (21.1)0
MDA 5/78 (14.8)1 (1.8)3 (5.5)10 (18.5)1 (1.8)
MDA 7/700000
DAPSA ≤ 4002 (8.6)7 (30.4)0
cDAPSA ≤ 4002 (7.1)7 (25)0
DAPSA LDA24 (30)6 (7.5)22 (27.5)17 (33.7)6 (7.5)
cDAPSA LDA23 (29.1)4 (5.1)21 (26.5)17 (21.5)5 (6.3)
  • PsA: psoriatic arthritis; PASDAS: Psoriatic Arthritis Disease Activity Score; LDA: low disease activity; MDA: minimal disease activity; DAPSA: Disease Activity Index for Psoriatic Arthritis; TJC: tender joint count; SJC: swollen joint count; HAQ: Health Assessment Questionnaire; PASI: Psoriasis Area Severity Index; LEI: Leeds Enthesitis Index; cDAPSA: clinical DAPSA.